The biotechnology company HIPRA has announced a strategic alliance with the Argentine laboratory LLAMAS Laboratorios, nationally recognized for its expertise and prestige in the veterinary field. The main objective of this alliance is to strengthen and optimize the diagnostic service for animal production in Argentina. This will be achieved by expanding the range of locally available tests, increasing the value of results for decision-making, and reducing turnaround times, among other advantages. This service, together with HIPRA’s vaccines, aims to prevent infectious diseases, thereby reducing related economic losses. 

The synergy with LLAMAS Laboratorios will be key due to its high technological level and presence in the Argentine field, perfectly complementing HIPRA’s technological and scientific capabilities to bring value to the country’s veterinary sector.

Both companies emphasize their joint commitment to quality, innovation, and sustainability, highlighting this alliance as a positive example of cooperation, respectful of all market players, open to future collaborations with third parties, and clearly aimed at benefiting professionals in the veterinary field. 

HIPRA Diagnos

HIPRA Diagnos is a comprehensive support service for field veterinarians that offers fast and reliable analytical testing, accompanied by specialized consultancy. Its goal is to prevent the emergence of the most impactful infectious diseases in animals and to guide decision-making in animal health and vaccination. 

The trust built around this HIPRA service over its 40 years of existence is reflected in its widespread use, with around 600,000 serological analyses, 80,000 molecular analyses, and 10,000 microbiological and parasitological analyses performed annually, among other specialized services.